CN110141677A - Absorbable material for local acute hemostasis and preparation method thereof - Google Patents
Absorbable material for local acute hemostasis and preparation method thereof Download PDFInfo
- Publication number
- CN110141677A CN110141677A CN201910489159.7A CN201910489159A CN110141677A CN 110141677 A CN110141677 A CN 110141677A CN 201910489159 A CN201910489159 A CN 201910489159A CN 110141677 A CN110141677 A CN 110141677A
- Authority
- CN
- China
- Prior art keywords
- preparation
- chitosan
- regenerated cellulose
- oxidized regenerated
- collagen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0042—Materials resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/043—Mixtures of macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/04—Materials for stopping bleeding
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Materials For Medical Uses (AREA)
Abstract
本发明涉及一种局部急性止血可吸收材料及其制备方法,通过以细菌纤维素为底物制备氧化再生纤维素,再与壳聚糖或者壳聚糖和胶原蛋白进行静电吸附自组装而得。本发明同时具备急性止血、广谱抗菌、促进愈合及体内吸收的特性;制备方法绿色环保,复合均匀高效,得到的复合材料安全性高,具有良好的市场应用前景。
The invention relates to an absorbable material for local acute hemostasis and a preparation method thereof. The oxidized regenerated cellulose is prepared by using bacterial cellulose as a substrate, and then electrostatically adsorbed and self-assembled with chitosan or chitosan and collagen. The invention also has the characteristics of acute hemostasis, broad-spectrum antibacterial, healing promotion and in vivo absorption; the preparation method is green and environmentally friendly, the compounding is uniform and efficient, and the obtained composite material has high safety and good market application prospect.
Description
技术领域technical field
本发明属于生物医用复合材料技术领域,特别涉及一种局部急性止血可吸收材料及其制备方法。The invention belongs to the technical field of biomedical composite materials, in particular to an absorbable material for local acute hemostasis and a preparation method thereof.
背景技术Background technique
可吸收止血材料是一种用于伤口出血部位,能够快速止血,并且在一定时间内能被人体吸收的生物医用材料。其最大特点在于:应用于人体或动物体内局部难缝合伤口止血,在实现快速止血的同时,可在体内降解、无需取出,从而避免止血完成后去除敷料的二次伤害。目前常用的可吸收止血材料有纤维蛋白胶类止血材料、明胶海绵类止血材料、氧化纤维素类止血材料及壳聚糖类止血材料等。这些止血材料的止血机理和使用方法各不相同,其止血效果也有很大差别。Absorbable hemostatic material is a biomedical material that can be used in the bleeding site of a wound, can quickly stop bleeding, and can be absorbed by the human body within a certain period of time. Its biggest feature is that it can be applied to local difficult-to-suture wounds in humans or animals to stop bleeding. While achieving rapid hemostasis, it can be degraded in the body without removing it, so as to avoid the secondary injury of removing the dressing after the hemostasis is completed. Currently commonly used absorbable hemostatic materials include fibrin glue hemostatic materials, gelatin sponge hemostatic materials, oxidized cellulose hemostatic materials and chitosan hemostatic materials. The hemostatic mechanisms and usage methods of these hemostatic materials are different, and their hemostatic effects are also very different.
氧化再生纤维素在1960年首次制备成功,是纤维素经氧化处理成为纤维素酸的薄纱状或棉布状可吸收止血材料,具有棉纱的外观和质地,柔软而菲薄,易于包、敷、填塞等操作。其止血机制是将手术创面血液中的血小板聚集在网眼纱布上,以止血纱布作为止血基质,遇血后迅速形成凝胶状黑色物质,凝结血块从而达到止血的目的。它不依赖于人体内正常的凝血机制,而是通过物理作用迅速促使血液凝固,有效控制小血管出血。目前,只有美国和英国能生产该类产品,临床上使用的可吸收止血纱布Surgicel(速即纱)就是美国强生公司的产品,速即纱的主要成分就是氧化再生纤维素。氧化再生纤维素将纤维素中的C6伯羟基高度选择性氧化成为羧基而得到的纤维素的一种衍生物,目前已被应用于各行各业,且市场销售的产品主要依赖于进口,国内仅有几家公司生产出了类似的止血纱布。虽然氧化再生纤维素有很多优异的性能,但也存在一些弊端,如止血效率不高,不能适用于大量出血,抗菌性能弱以及组织相容性低等。Oxidized regenerated cellulose was successfully prepared for the first time in 1960. It is a tissue-like or cotton-like absorbable hemostatic material in which cellulose is oxidized to become cellulose acid. It has the appearance and texture of cotton yarn, is soft and thin, and is easy to wrap, apply and pack. and so on. The hemostatic mechanism is to gather platelets in the blood of the surgical wound on the mesh gauze, and use the hemostatic gauze as the hemostatic matrix. After encountering blood, a gel-like black substance is formed quickly, and the blood clots are formed to achieve the purpose of hemostasis. It does not rely on the normal coagulation mechanism in the human body, but rapidly promotes blood coagulation through physical action, effectively controlling small blood vessel bleeding. At present, only the United States and the United Kingdom can produce such products. Surgicel, an absorbable hemostatic gauze used clinically, is a product of Johnson & Johnson in the United States. The main component of Surgicel is oxidized regenerated cellulose. Oxidized regenerated cellulose is a derivative of cellulose obtained by highly selective oxidation of C6 primary hydroxyl groups in cellulose into carboxyl groups. At present, it has been used in all walks of life, and the products sold in the market mainly rely on imports. Several companies have produced similar hemostatic gauze. Although oxidized regenerated cellulose has many excellent properties, it also has some disadvantages, such as low hemostatic efficiency, inability to apply to massive bleeding, weak antibacterial properties and low histocompatibility.
目前,在一些公开或授权的发明专利中,已经使用天然/合成高分子材料或者无机材料对氧化再生纤维素进行改性来提高其抗菌和止血性能。如胶原蛋白(CN105079886A)、藻酸盐(CN104013991A)和碳纳米管(CN105056284A)等。虽然以上复合止血材料对氧化再生纤维素性能有了一定的提升,但是改善效果较差,只能提升其部分性能,并且会对材料的生物可吸收性能造成负面影响。At present, in some published or authorized invention patents, natural/synthetic polymer materials or inorganic materials have been used to modify oxidized regenerated cellulose to improve its antibacterial and hemostatic properties. Such as collagen (CN105079886A), alginate (CN104013991A) and carbon nanotubes (CN105056284A). Although the above composite hemostatic materials have improved the properties of oxidized regenerated cellulose to a certain extent, the improvement effect is poor, only part of its properties can be improved, and the bioabsorbable properties of the materials will be negatively affected.
发明内容SUMMARY OF THE INVENTION
本发明所要解决的技术问题是提供一种局部急性止血可吸收材料及其制备方法,解决了氧化再生纤维素抗菌性能弱、组织相容性低、止血速度慢的问题。The technical problem to be solved by the present invention is to provide an absorbable material for local acute hemostasis and a preparation method thereof, which solve the problems of weak antibacterial properties of oxidized regenerated cellulose, low histocompatibility and slow hemostasis.
本发明提供了一种局部急性止血可吸收材料,通过以细菌纤维素为底物制备氧化再生纤维素(OBC),再与壳聚糖或者壳聚糖和胶原蛋白进行静电吸附自组装而得。The invention provides an absorbable material for local acute hemostasis, which is obtained by using bacterial cellulose as a substrate to prepare oxidized regenerated cellulose (OBC), and then performing electrostatic adsorption and self-assembly with chitosan or chitosan and collagen.
所述细菌纤维素是通过以木醋杆菌为菌种,经液体培养基恒温静置培养7-20天后,置于氢氧化钠溶液中,在70-90℃下处理2-4h后取出,用去离子水漂洗至中性后获得。The bacterial cellulose is obtained by using Acetobacter xylinum as a strain, and after culturing it at a constant temperature in a liquid medium for 7-20 days, placing it in a sodium hydroxide solution, treating it at 70-90° C. for 2-4 hours, taking out, and using Obtained after rinsing with deionized water until neutral.
本发明还提供了一种局部急性止血可吸收材料的制备方法,包括:The present invention also provides a preparation method of a local acute hemostatic absorbable material, comprising:
(1)以细菌纤维素为底物,制备氧化再生纤维素悬浊液;(1) using bacterial cellulose as a substrate to prepare an oxidized regenerated cellulose suspension;
(2)将壳聚糖/稀酸溶液逐滴加入到氧化再生纤维素悬浊液中进行静电吸附自组装反应,然后取出,漂洗,冻干,得到局部急性止血可吸收材料(氧化再生纤维素/壳聚糖可吸收抗菌止血材料OC);(2) adding the chitosan/dilute acid solution dropwise to the oxidized regenerated cellulose suspension for electrostatic adsorption self-assembly reaction, then taking out, rinsing, and freeze-drying to obtain a local acute hemostatic absorbable material (oxidized regenerated cellulose / Chitosan absorbable antibacterial hemostatic material OC);
或者,将胶原蛋白水溶液加入到氧化再生纤维素悬浊液中浸渍吸附,再将壳聚糖/稀酸溶液逐滴加入到氧化再生纤维素悬浊液中进行静电吸附自组装反应,然后取出,漂洗,冻干,得到局部急性止血可吸收材料(氧化再生纤维素/胶原/壳聚糖可吸收抗菌止血材料OCC)。Alternatively, the collagen aqueous solution is added to the oxidized regenerated cellulose suspension for immersion and adsorption, and then the chitosan/dilute acid solution is added dropwise to the oxidized regenerated cellulose suspension for electrostatic adsorption and self-assembly reaction, and then taken out, Rinse and freeze-dry to obtain local acute hemostatic absorbable material (oxidized regenerated cellulose/collagen/chitosan absorbable antibacterial hemostatic material OCC).
所述步骤(1)中的氧化再生纤维素悬浊液的制备步骤如下:将细菌纤维素膜打散,经TEMPO/NaBr/NaClO混合氧化体系于室温下氧化,离心清洗和透析后得到。The preparation steps of the oxidized regenerated cellulose suspension in the step (1) are as follows: the bacterial cellulose membrane is broken up, oxidized in a TEMPO/NaBr/NaClO mixed oxidation system at room temperature, and obtained after centrifugal cleaning and dialysis.
所述步骤(2)中的壳聚糖/稀酸溶液是将壳聚糖溶解于0.1-5%的稀酸溶液中,形成终浓度为1-5%的壳聚糖/稀酸溶液。The chitosan/dilute acid solution in the step (2) is to dissolve chitosan in a 0.1-5% dilute acid solution to form a chitosan/dilute acid solution with a final concentration of 1-5%.
所述步骤(2)中的胶原蛋白为鱼源胶原;胶原蛋白水溶液的浓度为0.1-10mg/mL。The collagen in the step (2) is fish-derived collagen; the concentration of the collagen aqueous solution is 0.1-10 mg/mL.
所述步骤(2)中的胶原蛋白与氧化再生纤维素的质量比为1:1-10:1。The mass ratio of collagen to oxidized regenerated cellulose in the step (2) is 1:1-10:1.
所述步骤(2)中的浸渍吸附时间为0.5-5小时。The soaking adsorption time in the step (2) is 0.5-5 hours.
所述步骤(2)中的静电吸附自组装反应时间为1-60分钟。The electrostatic adsorption self-assembly reaction time in the step (2) is 1-60 minutes.
以细菌纳米纤维素为底物制备氧化再生纤维素(OBC),利用其高纯度和大比表面积特性,加快凝血过程。同时利用OBC和壳聚糖相反的电荷性,进行静电吸附自组装反应进行复合,还可以在其中引入胶原蛋白,制备得到同时具有急性止血、抗菌和促愈功能的可吸收复合材料。Oxidized regenerated cellulose (OBC) was prepared from bacterial nanocellulose as a substrate, and its high purity and large specific surface area were utilized to accelerate the coagulation process. At the same time, the opposite charge of OBC and chitosan is used to conduct electrostatic adsorption self-assembly reaction for composite, and collagen can also be introduced into it to prepare absorbable composite material with acute hemostasis, antibacterial and healing promotion functions.
有益效果beneficial effect
(1)本发明的局部急性止血可吸收材料以细菌纤维素为底物制备氧化再生纤维素,其羧基含量更高,比表面积更大,聚合度更低,止血效果更好,生物可降解性能更好,更容易被人体吸收。(1) The absorbable material for local acute hemostasis of the present invention uses bacterial cellulose as a substrate to prepare oxidized regenerated cellulose, which has higher carboxyl group content, larger specific surface area, lower degree of polymerization, better hemostatic effect, and biodegradable performance. Better and more easily absorbed by the body.
(2)本发明利用氧化再生纤维素与壳聚糖相反的电荷性进行静电吸附自组装制备,无需使用额外交联剂;同时,壳聚糖的加入提高了材料促凝血和抗菌特性。(2) The present invention utilizes the opposite charge properties of oxidized regenerated cellulose and chitosan for electrostatic adsorption self-assembly preparation, without using additional cross-linking agent; at the same time, the addition of chitosan improves the procoagulant and antibacterial properties of the material.
(3)本发明通过利用氧化再生纤维素大的比表面积,在充分吸附胶原蛋白分子之后再与壳聚糖进行静电吸附自组装反应,最终得到的材料同时具备急性止血、抗菌、促愈和可吸收的特性。(3) The present invention utilizes the large specific surface area of oxidized regenerated cellulose to conduct electrostatic adsorption and self-assembly reaction with chitosan after fully adsorbing collagen molecules. absorption properties.
(4)本发明原料均为绿色环保生物材料,不含对人体有害的化学物质,可根据实际情况和特点制备成各种形状,安全环保,丢弃后在环境中能迅速降解,可作为一种性能良好且绿色环保的功能性材料。(4) The raw materials of the present invention are all green and environmentally friendly biological materials, do not contain chemical substances harmful to the human body, can be prepared into various shapes according to actual conditions and characteristics, are safe and environmentally friendly, can be rapidly degraded in the environment after being discarded, and can be used as a kind of Functional materials with good performance and green environmental protection.
(5)本发明制备方法简单易行,复合均匀高效,不使用交联剂,不会对合成物质的原有结构造成破坏,绿色环保,可工业化生产,具有良好的市场应用前景。(5) The preparation method of the present invention is simple and feasible, the compounding is uniform and efficient, the cross-linking agent is not used, and the original structure of the synthetic substance is not damaged, and the invention is green and environmentally friendly, can be industrially produced, and has a good market application prospect.
附图说明Description of drawings
图1为本发明制备方法的流程示意图;Fig. 1 is the schematic flow sheet of the preparation method of the present invention;
图2为局部急性止血可吸收材料的产品图;其中,1为氧化再生纤维素(OBC),2为氧化再生纤维素/壳聚糖(OC),3为氧化再生纤维素/胶原蛋白/壳聚糖(OCC);Figure 2 is the product diagram of the absorbable material for topical acute hemostasis; wherein, 1 is oxidized regenerated cellulose (OBC), 2 is oxidized regenerated cellulose/chitosan (OC), and 3 is oxidized regenerated cellulose/collagen/shell glycans (OCC);
图3是实施例1-3在相同稀释倍数下对大肠杆菌和金黄色葡萄球菌的抑菌效果图,无菌纱布为对照组;Fig. 3 is the bacteriostatic effect diagram of embodiment 1-3 to Escherichia coli and Staphylococcus aureus under the same dilution ratio, and sterile gauze is a control group;
图4是实施例1-3的体外全血凝固时间测试结果。FIG. 4 is the results of the in vitro whole blood clotting time test of Examples 1-3.
具体实施方式Detailed ways
下面结合具体实施例,进一步阐述本发明。应理解,这些实施例仅用于说明本发明而不用于限制本发明的范围。此外应理解,在阅读了本发明讲授的内容之后,本领域技术人员可以对本发明作各种改动或修改,这些等价形式同样落于本申请所附权利要求书所限定的范围。The present invention will be further described below in conjunction with specific embodiments. It should be understood that these examples are only used to illustrate the present invention and not to limit the scope of the present invention. In addition, it should be understood that after reading the content taught by the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms also fall within the scope defined by the appended claims of the present application.
实施例1Example 1
(1)以木醋杆菌为菌种,经液体培养基恒温静置培养10天后,取出细菌纤维素膜置于氢氧化钠溶液中,在80℃下处理2h后取出,用去离子水漂洗至中性后获得细菌纤维素膜;浸泡于透明质酸溶液中6h,得到透明质酸浸泡后的细菌纤维素膜;(1) Using Acetobacter xylinum as the strain, after culturing at a constant temperature in the liquid medium for 10 days, take out the bacterial cellulose membrane and place it in sodium hydroxide solution, treat it at 80 °C for 2 hours, take it out, and rinse it with deionized water until After neutralization, bacterial cellulose membrane was obtained; soaked in hyaluronic acid solution for 6 hours to obtain bacterial cellulose membrane soaked in hyaluronic acid;
(2)称取4g纯化后的细菌纤维素膜,将其剪碎后在高速匀浆机中打散,成为细菌纤维素悬浊液。(2) Weigh 4 g of the purified bacterial cellulose membrane, cut it into pieces, and then disperse it in a high-speed homogenizer to obtain a bacterial cellulose suspension.
(3)将步骤(2)中得到的细菌纤维素悬浮液(固含量为1-10g/L)经TEMPO/NaBr/NaClO混合氧化体系于室温下进行氧化,TEMPO用量为0.1mmol/g,NaBr为1mmol/g。加入一定量的10%NaClO溶液开始反应,通过滴加0.5M NaOH溶液来维持反应体系的pH=10±0.5,至不再消耗NaOH溶液时,加入乙醇终止反应。得到的氧化产物经离心、漂洗和高压灭菌后置于4℃环境下保存。由电导滴定法测得TEMPO氧化再生纤维素悬浮液的羧基含量为23%。(3) the bacterial cellulose suspension (solid content is 1-10g/L) obtained in step (2) is oxidized at room temperature by TEMPO/NaBr/NaClO mixed oxidation system, the amount of TEMPO is 0.1mmol/g, NaBr is 1 mmol/g. A certain amount of 10% NaClO solution was added to start the reaction, and the pH of the reaction system was maintained at 10±0.5 by adding 0.5M NaOH solution dropwise. When the NaOH solution was no longer consumed, ethanol was added to terminate the reaction. The obtained oxidized product was stored at 4°C after centrifugation, rinsing and autoclaving. The carboxyl group content of the TEMPO oxidized regenerated cellulose suspension determined by conductometric titration was 23%.
(4)将步骤(3)得到的氧化再生纤维素悬浊液进行冷冻干燥,最后得到氧化再生纤维素止血材料。(4) freeze-drying the oxidized regenerated cellulose suspension obtained in step (3), and finally obtain the oxidized regenerated cellulose hemostatic material.
实施例2Example 2
(1)以木醋杆菌为菌种,经液体培养基恒温静置培养10天后,取出细菌纤维素膜置于氢氧化钠溶液中,在80℃下处理2h后取出,用去离子水漂洗至中性后获得细菌纤维素膜;浸泡于透明质酸溶液中6h,得到透明质酸浸泡后的细菌纤维素膜;(1) Using Acetobacter xylinum as the strain, after culturing at a constant temperature in the liquid medium for 10 days, take out the bacterial cellulose membrane and place it in sodium hydroxide solution, treat it at 80 °C for 2 hours, take it out, and rinse it with deionized water until After neutralization, bacterial cellulose membrane was obtained; soaked in hyaluronic acid solution for 6 hours to obtain bacterial cellulose membrane soaked in hyaluronic acid;
(2)称取4g纯化后的细菌纤维素膜,将其剪碎后在高速匀浆机中打散,成为细菌纤维素悬浊液。(2) Weigh 4 g of the purified bacterial cellulose membrane, cut it into pieces, and then disperse it in a high-speed homogenizer to obtain a bacterial cellulose suspension.
(3)将步骤(2)中得到的细菌纤维素悬浮液(固含量为1-10g/L)经TEMPO/NaBr/NaClO混合氧化体系于室温下进行氧化,TEMPO用量为0.1mmol/g,NaBr为1mmol/g。加入一定量的10%NaClO溶液开始反应,通过滴加0.5M NaOH溶液来维持反应体系的pH=10±0.5,至不再消耗NaOH溶液时,加入乙醇终止反应。得到的氧化产物经离心、漂洗和高压灭菌后置于4℃环境下保存。由电导滴定法测得TEMPO氧化再生纤维素悬浮液的羧基含量为23%。(3) the bacterial cellulose suspension (solid content is 1-10g/L) obtained in step (2) is oxidized at room temperature by TEMPO/NaBr/NaClO mixed oxidation system, the amount of TEMPO is 0.1mmol/g, NaBr is 1 mmol/g. A certain amount of 10% NaClO solution was added to start the reaction, and the pH of the reaction system was maintained at 10±0.5 by adding 0.5M NaOH solution dropwise. When the NaOH solution was no longer consumed, ethanol was added to terminate the reaction. The obtained oxidized product was stored at 4°C after centrifugation, rinsing and autoclaving. The carboxyl group content of the TEMPO oxidized regenerated cellulose suspension determined by conductometric titration was 23%.
(4)称取2g壳聚糖充分溶解于100mL 3%的醋酸溶液中,形成终浓度为2%的壳聚糖稀酸溶液。(4) Weigh 2 g of chitosan and fully dissolve it in 100 mL of 3% acetic acid solution to form a chitosan dilute acid solution with a final concentration of 2%.
(5)取5mL步骤(4)制备的壳聚糖稀酸溶液逐滴加入50mL步骤(3)制备的氧化再生纤维素悬浊液中,反应60分钟后将产物反复离心漂洗,最后进行冷冻干燥,得到氧化再生纤维素/壳聚糖复合止血材料。(5) 5 mL of the chitosan dilute acid solution prepared in step (4) was added dropwise to 50 mL of the oxidized regenerated cellulose suspension prepared in step (3), and after 60 minutes of reaction, the product was repeatedly centrifuged and rinsed, and finally freeze-dried, The oxidized regenerated cellulose/chitosan composite hemostatic material was obtained.
实施例3Example 3
(1)以木醋杆菌为菌种,经液体培养基恒温静置培养10天后,取出细菌纤维素膜置于氢氧化钠溶液中,在80℃下处理2h后取出,用去离子水漂洗至中性后获得细菌纤维素膜;浸泡于透明质酸溶液中6h,得到透明质酸浸泡后的细菌纤维素膜;(1) Using Acetobacter xylinum as the strain, after culturing at a constant temperature in the liquid medium for 10 days, take out the bacterial cellulose membrane and place it in sodium hydroxide solution, treat it at 80 °C for 2 hours, take it out, and rinse it with deionized water until After neutralization, bacterial cellulose membrane was obtained; soaked in hyaluronic acid solution for 6 hours to obtain bacterial cellulose membrane soaked in hyaluronic acid;
(2)称取4g纯化后的细菌纤维素膜,将其剪碎后在高速匀浆机中打散,成为细菌纤维素悬浊液。(2) Weigh 4 g of the purified bacterial cellulose membrane, cut it into pieces, and then disperse it in a high-speed homogenizer to obtain a bacterial cellulose suspension.
(3)将步骤(2)中得到的细菌纤维素悬浮液(固含量为1-10g/L)经TEMPO/NaBr/NaClO混合氧化体系于室温下进行氧化,TEMPO用量为0.1mmol/g,NaBr为1mmol/g。加入一定量的10%NaClO溶液开始反应,通过滴加0.5M NaOH溶液来维持反应体系的pH=10±0.5,至不再消耗NaOH溶液时,加入乙醇终止反应。得到的氧化产物经离心、漂洗和高压灭菌后置于4℃环境下保存。由电导滴定法测得TEMPO氧化再生纤维素悬浮液的羧基含量为23%。(3) the bacterial cellulose suspension (solid content is 1-10g/L) obtained in step (2) is oxidized at room temperature by TEMPO/NaBr/NaClO mixed oxidation system, the amount of TEMPO is 0.1mmol/g, NaBr is 1 mmol/g. A certain amount of 10% NaClO solution was added to start the reaction, and the pH of the reaction system was maintained at 10±0.5 by adding 0.5M NaOH solution dropwise. When the NaOH solution was no longer consumed, ethanol was added to terminate the reaction. The obtained oxidized product was stored at 4°C after centrifugation, rinsing and autoclaving. The carboxyl group content of the TEMPO oxidized regenerated cellulose suspension determined by conductometric titration was 23%.
(4)称取30mg的鱼源胶原蛋白充分溶解于10mL无菌水中,形成终浓度为3mg/mL的蛋白溶液。(4) Weigh 30 mg of fish-derived collagen and fully dissolve it in 10 mL of sterile water to form a protein solution with a final concentration of 3 mg/mL.
(5)取10mL步骤(4)制备的蛋白溶液加入40mL步骤(3)制备的氧化再生纤维素悬浊液中,充分搅拌吸附1小时,得到吸附有胶原蛋白的氧化再生纤维素悬浊液。(5) 10 mL of the protein solution prepared in step (4) was added to 40 mL of the oxidized regenerated cellulose suspension prepared in step (3), fully stirred and adsorbed for 1 hour to obtain an oxidized regenerated cellulose suspension with collagen adsorbed.
(6)称取2g壳聚糖充分溶解于100mL 3%的醋酸溶液中,形成终浓度为2%的壳聚糖稀酸溶液。(6) Weigh 2 g of chitosan and fully dissolve it in 100 mL of 3% acetic acid solution to form a chitosan dilute acid solution with a final concentration of 2%.
(7)取5mL步骤(6)制备的壳聚糖稀酸溶液逐滴加入50mL步骤(5)制备的吸附有胶原蛋白的氧化再生纤维素悬浊液中,反应60分钟后将产物反复离心漂洗,最后进行冷冻干燥,得到氧化再生纤维素/胶原蛋白/壳聚糖复合止血材料。(7) 5 mL of the chitosan dilute acid solution prepared in step (6) was added dropwise to 50 mL of the collagen-adsorbed oxidized regenerated cellulose suspension prepared in step (5), and the product was repeatedly centrifuged and rinsed after 60 minutes of reaction. Finally, freeze-drying is performed to obtain oxidized regenerated cellulose/collagen/chitosan composite hemostatic material.
由图3可知,与纱布相比较,氧化再生纤维素具有一定的抑菌作用,这主要是由于氧化再生纤维素中大量羧基形成的低pH环境抑制了细菌的增殖和繁殖。但是其抑菌效果是非常有限的,仍有相当数目的细菌存活。相反,复合有壳聚糖实验组(OC,OCC)的抗菌性能较氧化再生纤维素而言得到显著提升,并且对大肠杆菌和金黄色葡萄球菌具有相同抑菌趋势。优异的广谱抗菌性表明OCC具有应用于临床的潜力。It can be seen from Figure 3 that compared with gauze, oxidized regenerated cellulose has a certain antibacterial effect, which is mainly because the low pH environment formed by a large number of carboxyl groups in oxidized regenerated cellulose inhibits the proliferation and reproduction of bacteria. However, its bacteriostatic effect is very limited, and a considerable number of bacteria still survive. In contrast, the antibacterial properties of the experimental group compounded with chitosan (OC, OCC) were significantly improved compared with the oxidized regenerated cellulose, and had the same antibacterial trend against Escherichia coli and Staphylococcus aureus. The excellent broad-spectrum antibacterial activity indicates that OCC has the potential for clinical application.
由图4可知,OBC,OC,OCC的全血凝固时间分别为248s,220s和180s,表明OCC具有优异的止血性能。其机理可能是由于氧化再生纤维素,壳聚糖以及胶原蛋白三者的协同作用。这三种材料的促凝血性能在诸多文献中都已得到证实,本发明在不破坏原有结构的情况下将这三种材料巧妙地结合在一起,形成一种新的复合材料并获得优异的止血性能,有应用于临床作为急性止血材料的潜力。It can be seen from Figure 4 that the whole blood clotting times of OBC, OC and OCC are 248s, 220s and 180s, respectively, indicating that OCC has excellent hemostatic properties. The mechanism may be due to the synergistic effect of oxidized regenerated cellulose, chitosan and collagen. The procoagulant properties of these three materials have been confirmed in many literatures. The present invention combines these three materials ingeniously without destroying the original structure to form a new composite material and obtain excellent It has hemostatic properties and has the potential to be used clinically as an acute hemostatic material.
Claims (9)
- The absorbable material 1. a kind of topical acute stops blooding, it is characterised in that: by being aoxidized again by substrate preparation of bacteria cellulose Raw cellulose, then carry out Electrostatic Absorption self assembly with chitosan or chitosan and collagen and obtain.
- The absorbable material 2. a kind of topical acute according to claim 1 stops blooding, it is characterised in that: the bacteria cellulose Be by after fluid nutrient medium constant temperature stationary culture 7-20 days, being placed in sodium hydroxide solution using acetobacter xylinum as strain, It takes out after handling 2-4h at 70-90 DEG C, is obtained after being rinsed with deionized water to neutrality.
- 3. a kind of preparation method of topical acute hemostasis absorbable material, comprising:(1) using bacteria cellulose as substrate, oxidized regenerated cellulose suspension is prepared;(2) by chitosan/dilute acid soln be added dropwise in oxidized regenerated cellulose suspension carry out Electrostatic Absorption self assembly it is anti- It answers, then takes out, rinse, freeze-drying obtains topical acute hemostasis absorbable material;It is adsorbed alternatively, collagen aqueous solution is added to impregnate in oxidized regenerated cellulose suspension, then by chitosan/diluted acid Solution is added dropwise to progress Electrostatic Absorption self-assembling reaction in oxidized regenerated cellulose suspension, then takes out, and rinses, and freezes It is dry, obtain topical acute hemostasis absorbable material.
- 4. preparation method according to claim 3, it is characterised in that: the oxidized regenerated cellulose in the step (1) is outstanding The preparation step of turbid is as follows: bacteria cellulose film being broken up, at room temperature through TEMPO/NaBr/NaClO mixed oxidization system It is obtained after oxidation, eccentric cleaning and dialysis.
- 5. preparation method according to claim 3, it is characterised in that: chitosan/dilute acid soln in the step (2) is It dissolves the chitosan in the dilute acid soln of 0.1-5%, forms chitosan/dilute acid soln of final concentration of 1-5%.
- 6. preparation method according to claim 3, it is characterised in that: the collagen in the step (2) is source of fish glue It is former;The concentration of collagen aqueous solution is 0.1-10mg/mL.
- 7. the preparation method according to claim 3 or 6, it is characterised in that: collagen and oxidation in the step (2) The mass ratio of regenerated cellulose is 1:1-10:1.
- 8. preparation method according to claim 3, it is characterised in that: the dipping adsorption time in the step (2) is 0.5-5 hours.
- 9. preparation method according to claim 3, it is characterised in that: the Electrostatic Absorption self assembly in the step (2) is anti- It is 1-60 minutes between seasonable.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910489159.7A CN110141677B (en) | 2019-06-06 | 2019-06-06 | Local acute hemostasis absorbable material and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910489159.7A CN110141677B (en) | 2019-06-06 | 2019-06-06 | Local acute hemostasis absorbable material and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN110141677A true CN110141677A (en) | 2019-08-20 |
| CN110141677B CN110141677B (en) | 2022-07-08 |
Family
ID=67590334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910489159.7A Active CN110141677B (en) | 2019-06-06 | 2019-06-06 | Local acute hemostasis absorbable material and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110141677B (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110507844A (en) * | 2019-09-06 | 2019-11-29 | 东华大学 | A kind of absorbable composite material and preparation method for topical acute hemostasis based on oxidizing bacteria cellulose |
| CN111939314A (en) * | 2020-07-28 | 2020-11-17 | 天津科技大学 | A kind of preparation method of bacterial cellulose ointment for wound surface |
| CN112773941A (en) * | 2020-12-31 | 2021-05-11 | 东华大学 | Chitosan microsphere-bacterial cellulose composite material and preparation and application thereof |
| CN112773929A (en) * | 2020-12-31 | 2021-05-11 | 东华大学 | Absorbable hemostatic composite material based on polyanionic cellulose and preparation method thereof |
| CN114288480A (en) * | 2021-12-06 | 2022-04-08 | 盐城工学院 | A kind of biologically modified oxidized regenerated cellulose hemostatic anti-adhesion material and preparation method thereof |
| CN116370695A (en) * | 2023-03-17 | 2023-07-04 | 东华大学 | Absorbable hemostatic composite material for anti-inflammation and promoting healing of acute bleeding site and preparation method thereof |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4579943A (en) * | 1983-10-31 | 1986-04-01 | Asahi Kasei Kogyo Kabushiki Kaisha | Cellulose derivative excellent in liquid absorbing property, process for preparing same and structure containing same |
| WO2009012438A2 (en) * | 2007-07-18 | 2009-01-22 | Marine Polymer Technologies | Application of polymeric materials to screens to facilitate hemostasis and wound healing |
| US20130004478A1 (en) * | 2011-06-30 | 2013-01-03 | Yi-Lan Wang | Procoagulant Peptides and Their Derivatives and Uses Therefor |
| CN102908651A (en) * | 2012-10-30 | 2013-02-06 | 威高集团有限公司 | Preparation method of oxidized regenerated cellulose hemostatic material with micro-nano composite structure |
| CN103550817A (en) * | 2013-10-29 | 2014-02-05 | 上海昌颌医药科技有限公司 | Bacterial cellulose/chitosan composite sponge dressing and preparation method thereof |
| CN104383587A (en) * | 2014-12-01 | 2015-03-04 | 哈尔滨工业大学 | Fullerene/oxidized regenerated cellulose composite hemostatic material and preparation method thereof |
| CN106178066A (en) * | 2015-05-07 | 2016-12-07 | 中国科学院化学研究所 | A kind of modified cellulose/chitosan compound hemostatic material and preparation method and application |
| CN106806934A (en) * | 2015-11-30 | 2017-06-09 | 惠众国际医疗器械(北京)有限公司 | A kind of antibacterial repair function dressing and preparation method thereof |
| CN109023960A (en) * | 2018-06-08 | 2018-12-18 | 滨州亚光家纺有限公司 | One kind being based on supercritical CO2Fluid technique makes processing method of the cellulose fibre with crease-resistant function |
-
2019
- 2019-06-06 CN CN201910489159.7A patent/CN110141677B/en active Active
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4579943A (en) * | 1983-10-31 | 1986-04-01 | Asahi Kasei Kogyo Kabushiki Kaisha | Cellulose derivative excellent in liquid absorbing property, process for preparing same and structure containing same |
| WO2009012438A2 (en) * | 2007-07-18 | 2009-01-22 | Marine Polymer Technologies | Application of polymeric materials to screens to facilitate hemostasis and wound healing |
| US20130004478A1 (en) * | 2011-06-30 | 2013-01-03 | Yi-Lan Wang | Procoagulant Peptides and Their Derivatives and Uses Therefor |
| CN102908651A (en) * | 2012-10-30 | 2013-02-06 | 威高集团有限公司 | Preparation method of oxidized regenerated cellulose hemostatic material with micro-nano composite structure |
| CN103550817A (en) * | 2013-10-29 | 2014-02-05 | 上海昌颌医药科技有限公司 | Bacterial cellulose/chitosan composite sponge dressing and preparation method thereof |
| CN104383587A (en) * | 2014-12-01 | 2015-03-04 | 哈尔滨工业大学 | Fullerene/oxidized regenerated cellulose composite hemostatic material and preparation method thereof |
| CN106178066A (en) * | 2015-05-07 | 2016-12-07 | 中国科学院化学研究所 | A kind of modified cellulose/chitosan compound hemostatic material and preparation method and application |
| CN106806934A (en) * | 2015-11-30 | 2017-06-09 | 惠众国际医疗器械(北京)有限公司 | A kind of antibacterial repair function dressing and preparation method thereof |
| CN109023960A (en) * | 2018-06-08 | 2018-12-18 | 滨州亚光家纺有限公司 | One kind being based on supercritical CO2Fluid technique makes processing method of the cellulose fibre with crease-resistant function |
Non-Patent Citations (6)
| Title |
|---|
| HAIBIN YUAN ET AL.: "A Biodegradable Antibacterial Nanocomposite Based on Oxidized Bacterial Nanocellulose for Rapid Hemostasis and Wound Healing", 《AMERICAN CHEMICAL SOCIETY》 * |
| HUAN CHENG ET AL.: "Facile preparation of polysaccharide-based sponges and their potential application in wound dressin", 《J. MATER. CHEM. B》 * |
| QUN YANG ET AL.: "Improved thermal and mechanical properties of bacterial cellulose with the introduction of collagen", 《CELLULOSE》 * |
| 张鹏等: "原位细菌合成纤维素/壳聚糖纳米纤维凝胶膜", 《纤维素科学与技术》 * |
| 王珊: "《环境友好型高分子材料的制备与应用》", 31 December 2017, 北京工业大学出版社 * |
| 陈文彬等: "银负载细菌纤维素纳米复合材料的制备及抗菌性能研究", 《材料导报B:研究篇》 * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110507844A (en) * | 2019-09-06 | 2019-11-29 | 东华大学 | A kind of absorbable composite material and preparation method for topical acute hemostasis based on oxidizing bacteria cellulose |
| CN111939314A (en) * | 2020-07-28 | 2020-11-17 | 天津科技大学 | A kind of preparation method of bacterial cellulose ointment for wound surface |
| CN112773941A (en) * | 2020-12-31 | 2021-05-11 | 东华大学 | Chitosan microsphere-bacterial cellulose composite material and preparation and application thereof |
| CN112773929A (en) * | 2020-12-31 | 2021-05-11 | 东华大学 | Absorbable hemostatic composite material based on polyanionic cellulose and preparation method thereof |
| CN114288480A (en) * | 2021-12-06 | 2022-04-08 | 盐城工学院 | A kind of biologically modified oxidized regenerated cellulose hemostatic anti-adhesion material and preparation method thereof |
| CN116370695A (en) * | 2023-03-17 | 2023-07-04 | 东华大学 | Absorbable hemostatic composite material for anti-inflammation and promoting healing of acute bleeding site and preparation method thereof |
| CN116370695B (en) * | 2023-03-17 | 2025-03-25 | 东华大学 | An absorbable hemostatic composite material for anti-inflammatory and healing promotion of acute bleeding sites and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN110141677B (en) | 2022-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110141677A (en) | Absorbable material for local acute hemostasis and preparation method thereof | |
| CN110507844A (en) | A kind of absorbable composite material and preparation method for topical acute hemostasis based on oxidizing bacteria cellulose | |
| Tavakoli et al. | Natural polymers in wound healing: From academic studies to commercial products | |
| CN112300420B (en) | An injectable antibacterial interpenetrating double network hydrogel and its preparation method and application | |
| Zhang et al. | Application status and technical analysis of chitosan-based medical dressings: a review | |
| JP4896731B2 (en) | Wound dressing material with antioxidant and antibacterial properties | |
| CN102961777B (en) | Method for preparing porous compound type high permeability absorption hemostasis coating with modified nano-crystalline cellulose | |
| CN112972749B (en) | High-efficiency hemostatic material based on chitosan fiber and preparation method thereof | |
| JP2008532662A (en) | Method for producing antimicrobial wound dressing and use thereof | |
| CN108853570B (en) | Hemostatic sponge and preparation method thereof | |
| CN113769156A (en) | Hybrid fiber sponge with functions of hemostasis and wound repair and preparation method thereof | |
| CN116271204B (en) | A clay mineral-based hemostatic, antibacterial and healing-promoting hydrogel and preparation method thereof | |
| CN103848926B (en) | A kind of preparation method of using carboxyl chitosan and purposes | |
| CN100411690C (en) | A kind of preparation method of antibacterial polyelectrolyte porous material | |
| CN114767925B (en) | Fluorescent pH-sensitive antibacterial hydrogel dressing and preparation method and application thereof | |
| CN102210884A (en) | Preparation method of antibacterial dressing for promoting wound healing | |
| CN111073001A (en) | A kind of amphoteric glucan hydrogel and application | |
| CN106344954A (en) | Bio-antimicrobial bacterial cellulose dressing and preparation method thereof | |
| Xie et al. | Benign separated cellulose adhesive hydrogel via constructing double dynamic covalent bonds for ultra-fast hemostasis and antibacterial | |
| CN111068103B (en) | A kind of long-acting antibacterial gel dressing for surgical wound and preparation method thereof | |
| CN113908330B (en) | Preparation method of composite gel with photothermal antibacterial hemostatic characteristics, product and application thereof | |
| CN106975098B (en) | Composite polysaccharide hemostatic composition and preparation method and application thereof | |
| JP4486304B2 (en) | Microbial cellulosic wound dressings for the treatment of chronic wounds | |
| CN101700408A (en) | Novel gluconacetobacter xylinus cellulose hydrogel dressing and manufacturing method thereof | |
| JP4896714B2 (en) | Antioxidant wound dressing material |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |